Rheumatology Medical News about Spondyloarthropathy

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Rapid correction of low vitamin D status in nursing home residents

3. 2008 Exclusive Survey—Earnings: Good news for primary care income

4. Medicare pay-for-reporting effort draws fire from frustrated doctors

5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Other Future Targeting Therapy Beyond TNF-alpha Inhibitor in Patients with Spondyloarthropathy
Current Rheumatology Reviews, 09/10/09

Tsai W–C et al. – The efficacy of tumor necrosis factor blockage in patients with spondyloarthropathy is almost as effective as in patients with rheumatoid arthritis. New insight of pathogenesis uncovered novel molecules involved, which were potential targets in the future.

<< Previous
A haplotype in STAT4 gene associated with rheumatoid arthritis in...

Next >>
Anti Tumor Necrosis Factor Alpha (TNF) Therapy in Ankylosing...

Clinical utility of ultrasonography in spondyloarthropathies
Current Rheumatology Reports, 10/14/09 Relevance Score: 87%

Infliximab treatment in patients with rheumatoid arthritis and spondyloarthropathies in one rheumatological center: two years drug survival
Rheumatology International, 10/14/09 Relevance Score: 83%

Insights into the pathogenesis of axial spondyloarthropathy based on gene expression profiles
Arthritis Research & Therapy, 11/13/09 Relevance Score: 80%